نتایج جستجو برای: intravitreal vegf inhibitor agent

تعداد نتایج: 480981  

Journal: :Vision Research 2004
Hua Gao Xiaoxi Qiao Rui Gao William F. Mieler Alice R. McPherson Eric R. Holz

Intravitreal triamcinolone inhibits choroidal neovascularization. To investigate if vascular endothelial growth factor (VEGF) is affected, we examined VEGF expression after intravitreal triamcinolone administration in rat retina. Using in situ hybridization, we have found dense clustered VEGF mRNA signals in the retinal pigment epithelium, moderate patchy signals in the inner nuclear layer, and...

Journal: :Investigative ophthalmology & visual science 2011
Wei-Chi Wu Chih-Chun Chen Chi-Hsien Liu Nan-Kai Wang Kuan-Jen Chen Tun-Lu Chen Yih-Shiou Hwang Lien-Min Li Chi-Chun Lai

PURPOSE To investigate the clearance of vascular endothelial growth factor (VEGF) after the induction of posterior vitreous detachment by plasmin and/or SF(6). METHODS The study design included four groups of rabbits: group 1 received an intravitreal injection of plasmin and SF(6) in the right eye, group 2 received an intravitreal injection of plasmin in the right eye, group 3 received an int...

2015
Alina Adriana Ivanescu Patricia Fernández-Robredo Henar Heras-Mulero Luis Manuel Sádaba-Echarri Laura García-García Vanessa Fernández-García Maite Moreno-Orduna Aitor Redondo-Exposito Sergio Recalde Alfredo García-Layana

We examined the effect of nutritional supplements (modified Age Related Eye Disease Study (AREDS)-II formulation containing vitamins, minerals, lutein, resveratrol, and omega-3 fatty acids) on choroidal neovascularization (CNV). Supplements were administered alone and combined with intravitreal anti-VEGF in an early-CNV (diode laser-induced) murine model. Sixty mice were evenly divided into gro...

Journal: :British journal of pharmacy 2022

Age-related macular degeneration (AMD) is a potentially blinding posterior segment disease; inflammatory responses and subretinal drusen formation lead to leaky blood vessels. The current treatment method involves intravitreal injections of anti-VEGF agents, which highly invasive requires frequent administered by trained personnel. Periocular such as trans-/intra-scleral would provide minimally...

2018
Akira Hirata Ken Hayashi Kazuhisa Murata Kei-ichiro Nakamura

Purpose The formation of macular hole after receiving anti-vascular endothelial growth factor (anti-VEGF) therapy is rare. We report a case of macular hole that occurred after intravitreal injection of an anti-VEGF agent for age-related macular degeneration (AMD) in a patient, who underwent vitrectomy combined with choroidal neovascularization (CNV) removal. Observations A 64-year-old female ...

2014
Ulla Edén Neil Lagali Anette Dellby Tor P Utheim Ruth Riise Xiangjun Chen Per Fagerholm

roidal neovascularization with similar efficacy as anti-VEGF antibodies (Rennel et al. 2011). Several studies have shown that the simultaneous blockade of Ang-2/Tie2 and VEGF pathways reduces vascular leakage and tumour sprouting angiogenesis and has an additive effect to single-agent treatment without apparent increased systemic toxicity (Koh et al. 2010). Combined inhibition of Tie-2 and VEGF...

Journal: :iranian red crescent medical journal 0
ladan akbarzadeh department of pharmacology, shahid beheshti university, tehran, ir iran; department of pharmacology, shahid beheshti university, tehran, ir iran. tel: +98-9121034458, fax: +98-2122439969 taraneh moini zanjani department of pharmacology, shahid beheshti university, tehran, ir iran masoumeh sabetkasaei department of pharmacology, shahid beheshti university, tehran, ir iran

conclusions vpa and cbz treatments caused a decrease in β-catenin and vegf levels in sw480 colon cancer cell lines. these results suggest that cbz can be considered a potential antitumor drug with potencies different from vpa. methods in the present experimental study, implemented during 2014 - 2015 in iran, after incubation of cells into 96-well plates with 5,500 cells/well, the tested drugs w...

2017
Thomas Bertelmann Hans Ulrich Frank Hendrik Ansgar Fuchs Nicolas Feltgen

PURPOSE To report a case with ischemic macular edema (ME) due to an acute branch retinal vein occlusion (BRVO) which was treated with repeated intravitreal anti-VEGF injections. METHODS Retrospective case presentation. RESULTS A 66-year-old female patient was treated with repeated intravitreal anti-VEGF injections due to ischemic ME following an acute BRVO. Over a period of 2.5 years best c...

Journal: :American journal of ophthalmology 2012
Makiko Matsumoto Kiyoshi Suzuma Toshihide Maki Hirofumi Kinoshita Eiko Tsuiki Azusa Fujikawa Takashi Kitaoka

PURPOSE To examine vitreous succinate levels from proliferative diabetic retinopathy (PDR) patients and ascertain their association with PDR activity. DESIGN Comparative case series. METHODS A total of 81 eyes of 72 PDR patients were divided into active PDR (22 eyes), quiescent PDR (21 eyes), and active PDR with intravitreal bevacizumab injection (38 eyes). Twenty epiretinal membrane (ERM) ...

2014
Ahmad M Mansour J Fernando Arevalo Eman Al Kahtani Hernando Zegarra Emad Abboud Rajiv Anand Hamid Ahmadieh Robert A Sisk Salman Mirza Samuray Tuncer Amparo Navea Tejerina Jorge Mataix Francisco J Ascaso Jose S Pulido Rainer Guthoff Winfried Goebel Young Jung Roh Alay S Banker Ronald C Gentile Isabel Alonso Martinez Rodney Morris Neeraj Panday Park Jung Min Emilie Mercé Timothy Y Y Lai Vicky Massoud Nicola G Ghazi

We treated 26 eyes of 25 young patients having a mean age of 30 years with intravitreal vascular endothelial growth factor (VEGF) inhibitor for choroidal new vessel (CNV) formation overlying choroidal osteoma over a mean follow-up of 26 months. Mean number of injections was 2.4 at 6 months, 3.2 at 12 months, and 5.5 at 24 months. CNV was subfoveal in 14 eyes, juxtafoveal in 5, extrafoveal in 5,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید